Astec LifeSciences Limited announced the outcome of its Board Meeting held on January 30, 2026. The Board approved the unaudited financial results for the quarter and nine months ended December 31, 2025, on a standalone and consolidated basis. The limited review reports from the statutory auditors, with an unmodified opinion, were also noted. Furthermore, the Board accepted the resignation of Ms. Mugdha Amol Khare as the Chief Financial Officer, effective March 6, 2026. Concurrently, the Board approved the appointment of Mr. Deepak Jawaharlal Ochani as the new Chief Financial Officer, effective April 1, 2026. Mr. Ochani is a qualified Chartered Accountant with over 11 years of experience, including 9 years with the Godrej Agrovet group, bringing expertise in financial management and governance.
